Parexo Labs, a division of Azaya, launches as a new CDMO with an emphasis on nanotechnology and liposomal manufacturing. Azaya Therapeutics, a biopharmaceutical company focused on focused on ...

BRIDGEPORT — A local man was sentenced Tuesday to 35 years in prison for fatally shooting the father of a 6-year-old girl behind an East Main Street apartment building two years ago. Azaya “Lil Zay” ...

SAN ANTONIO--(BUSINESS WIRE)--Azaya Therapeutics Inc., a clinical-stage oncology company developing more effective cancer treatments through its nanotechnology platform, announced an exclusive license ...

Azaya Therapeutics is conducting a study of a generic version of a popular drug used to treat ovarian cancer. The company hopes that drug will fill a gap in the market next year. Azaya’s drug is ...

Cytori Therapeutics said today it plans to acquire the liposomal nanoparticle technology platform of Azaya Therapeutics for up to $170 million, in a deal designed to expand and complement the buyer’s ...

Azaya Therapeutics Inc. has licensed a technology that could be beneficial in treating head and neck cancers, the company said Wednesday. The technology involves the use of liposomes to deliver ...

San Antonio pharmaceutical firm Azaya Therapeutics Inc. has accused its founder and his new company of swiping a patent that's the basis of Azaya's efforts at developing safer cancer treatments. Azaya ...

Cytori Therapeutics Inc. stock surged 7.9% to $1.78 per share in morning trade Thursday after the company said it had agreed to purchase assets from privately-held Azaya Therapeutics. Under the terms ...

> We all know that one of the most valuable resources in the clinical research industry is experienced staff. Yet it is commonly accepted that a clinical monitor will only stay with a company for ...

SAN ANTONIO The National Cancer Institute has selected Azaya Therapeutics for a collaboration study of the company’s lead investigational cancer therapy, Azaya announced Monday. The studies, to be ...